Synapse

← Eric D. Peterson

Papers by Eric D. Peterson

Page 6 · newest first

  1. Identifying Nonclinical Factors Associated With 30-Day Readmission in Patients with Cardiovascular Disease: Protocol for an Observational StudyJMIR Research Protocols · 2017
  2. Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage OutcomesStroke · 2017
  3. Familial clustering of atrial fibrillation and comparative longitudinal outcomes of familial and non-familial atrial fibrillationJournal of Comparative Effectiveness Research · 2017
  4. An Initial Evaluation of the Impact of Pokémon GO on Physical ActivityJournal of the American Heart Association · 2017
  5. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA GuidelinesJAMA · 2017
  6. Factors associated with non–vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)American Heart Journal · 2017
  7. Importance of balancing follow-up time and impact of oral-anticoagulant users’ selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixabanCurrent Medical Research and Opinion · 2017
  8. Assessment and provision of rehabilitation among patients hospitalized with acute ischemic stroke in China: Findings from the China National Stroke Registry IIInternational Journal of Stroke · 2017
  9. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II])The American Journal of Cardiology · 2017
  10. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF])The American Journal of Cardiology · 2017
  11. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial FibrillationJAMA · 2017
  12. The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart AssociationCirculation · 2017
  13. Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registryEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2017
  14. Healthcare Resource Availability, Quality of Care, and Acute Ischemic Stroke OutcomesJournal of the American Heart Association · 2017
  15. Race and Sex Differences in Post–Myocardial Infarction Angina Frequency and Risk of 1-Year Unplanned RehospitalizationCirculation · 2017
  16. Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non–Vitamin K Antagonist Oral Anticoagulants Before StrokeCirculation · 2017
  17. Outcomes of a multi‐community hypertension implementation study: the American Heart Association's Check. Change. Control. programJournal of Clinical Hypertension · 2017
  18. Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)Diabetes Care · 2017
  19. Primary health care providers' roles and responsibilities: A qualitative exploration of ‘who does what’ in the treatment and management of persons affected by obesityJournal of Communications In Healthcare · 2017
  20. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical PracticeCirculation Cardiovascular Quality and Outcomes · 2017
  21. Hospital Variation in Functional Recovery After StrokeCirculation Cardiovascular Quality and Outcomes · 2017
  22. Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart FailureCirculation Cardiovascular Quality and Outcomes · 2017
  23. Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial FibrillationJAMA Cardiology · 2016
  24. Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse OutcomesJournal of the American College of Cardiology · 2016
  25. Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial FibrillationThe American Journal of Medicine · 2016
  26. Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyCirculation · 2016
  27. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCINew England Journal of Medicine · 2016
  28. Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease IncidenceJAMA · 2016
  29. Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke PopulationCirculation · 2016
  30. Intensive Care Unit Utilization and Mortality Among Medicare Patients Hospitalized With Non–ST-Segment Elevation Myocardial InfarctionJAMA Cardiology · 2016
  31. Cardioversion and subsequent quality of life and natural history of atrial fibrillationAmerican Heart Journal · 2016
  32. Impact of Insurance Status on Outcomes and Use of Rehabilitation Services in Acute Ischemic Stroke: Findings From Get With The Guidelines‐StrokeJournal of the American Heart Association · 2016
  33. Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOSDiabetes Care · 2016
  34. Substantial Progress Yet Significant Opportunity for Improvement in Stroke Care in ChinaStroke · 2016
  35. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) RegistryJournal of the American Heart Association · 2016
  36. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE‐ACS) StudyJournal of the American Heart Association · 2016
  37. Why are acute ischemic stroke patients not receiving IV tPA?Neurology · 2016
  38. Hospital Variation in Home-Time After Acute Ischemic StrokeStroke · 2016
  39. Sitagliptin and risk of fractures in type 2 diabetes: R esults from the TECOS trialDiabetes Obesity and Metabolism · 2016
  40. Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and TreatmentJAMA Cardiology · 2016
  41. Variation in Hospital Risk–Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United StatesCirculation Cardiovascular Quality and Outcomes · 2016
  42. Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE‐ACS) StudyJournal of the American Heart Association · 2016
  43. Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid–Eligible Adults With Myocardial InfarctionJAMA Cardiology · 2016
  44. Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of AgeStroke · 2016
  45. Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart FailureCirculation · 2016
  46. Prior Antithrombotic Use Is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic StrokeStroke · 2016
  47. Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary InterventionJAMA Cardiology · 2016
  48. Outcomes 1 Year After Implantable Cardioverter–Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning LeadsCirculation Arrhythmia and Electrophysiology · 2016
  49. Zika Virus Surveillance and Preparedness — New York City, 2015–2016MMWR Morbidity and Mortality Weekly Report · 2016
  50. Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart FailureCirculation Heart Failure · 2016